Additional reported effects include antioxidant activity, genomic regulatory effects, and immune modulation [1]
The Semaglutide side effect profile indicates that it significantly affects the metabolic and digestive systems, ranging from nausea, vomiting, diarrhea, and abdominal pain, to serious risks, such as pancreatitis, gallbladder disease, acute kidney injury, and NAION (vision loss risk) besides boxed warning risk of thyroid C-cell tumors (observed in animal studies) and Other concerns like muscle loss with rapid weight reduction, high likelihood of weight regain on discontinuing therapy with Semaglutide
High-fat meals and foods can delay gastric emptying, meaning it takes longer for the stomach contents to move into the small intestine
The ability to reduce body weight is consistently observed in individuals taking SGLT2 inhibitors, but this weight loss is moderate due to counter-regulatory mechanisms striving to maintain body weight